CapForce, Inc. (CFOR)
6.02
-0.88
(-12.75%)
USD |
OTCM |
Nov 05, 16:00
CapForce Profit Margin (Quarterly) : 84.94% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 84.94% |
| March 31, 2026 | |
| December 31, 2025 | 80.64% |
| September 30, 2025 | |
| June 30, 2025 | 87.75% |
| March 31, 2025 | |
| December 31, 2024 | 87.00% |
| September 30, 2024 | |
| June 30, 2024 | -5.63K% |
| March 31, 2024 | |
| December 31, 2023 | -1.59K% |
| September 30, 2023 | -581.3% |
| June 30, 2023 | -791.6% |
| March 31, 2023 | -628.0% |
| December 31, 2022 | -1.46K% |
| September 30, 2022 | -3.14K% |
| June 30, 2022 | -603.8% |
| March 31, 2022 | -1.45K% |
| December 31, 2021 | -484.4% |
| September 30, 2021 | -488.8% |
| June 30, 2021 | -873.2% |
| March 31, 2021 | -1.79K% |
| December 31, 2020 | -525.8% |
| September 30, 2020 | -726.3% |
| Date | Value |
|---|---|
| June 30, 2020 | -629.0% |
| March 31, 2020 | -640.2% |
| December 31, 2019 | -306.8% |
| September 30, 2019 | -537.2% |
| June 30, 2019 | -256.9% |
| March 31, 2019 | -377.7% |
| December 31, 2018 | -491.8% |
| September 30, 2018 | -589.5% |
| June 30, 2018 | -422.4% |
| March 31, 2018 | -360.2% |
| December 31, 2017 | -296.5% |
| September 30, 2017 | -438.7% |
| June 30, 2017 | -598.4% |
| March 31, 2017 | -645.0% |
| December 31, 2016 | -472.9% |
| September 30, 2016 | -638.1% |
| June 30, 2016 | -427.2% |
| March 31, 2016 | -418.6% |
| December 31, 2015 | -355.6% |
| September 30, 2015 | -476.2% |
| June 30, 2015 | -1.43K% |
| March 31, 2015 | -549.6% |
| December 31, 2013 | -472.7% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Phio Pharmaceuticals Corp. | -- |
| Agenus, Inc. | -1.64% |
| Amgen, Inc. | 37.29% |
| Anika Therapeutics, Inc. | 10.15% |
| BioCryst Pharmaceuticals, Inc. | 21.03% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 196.8% |
| Return on Assets | 164.7% |
| Return on Invested Capital | 185.2% |
| Gross Profit Margin (Quarterly) | 89.90% |
| Operating Margin (Quarterly) | 88.57% |
| Return on Net Operating Assets | 460.5% |